AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases.
Glassdoor
Employee Ratings3.4 / 511 reviews
69% recommend to a friend
$196.5M
Market Cap • 02/06/20232003
(20 years ago)
2016
(7 years ago)
Lausanne
156
Employees • 2022Valuation
Company FinancialsValuation Indicators
Valuation Indicators| Year | Equity | Revenue | EBITDA | Fin. Res. | Net Inc. | Net Mar. | ROE | Cash | Debt | N.D. / EBITDA | OCF | CAPEX | FCF | Free | Div. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/23 TTM | 167 | 4 | -73 | 0 | -76 | L | L | 115 | 3 | L | -73 | -1 | -1 | -74 | 0 |
The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.